The Ethical Implications of For-Profit Financing Models in Medical Practices and Institutions
Presented by the Committee on Ethics, Grievances, and Professional Standards, the Ethics Forum alerts physicians to the ethical implications of issues that arise in daily practice and offers information on issues at the intersection of ethics, medicine,
and professionalism. This Ethics Forum (previously recorded on November 30, 2022 as part of the Massachusetts Medical Society’s Interim Meeting) explores ethical implications of for-profit financing models in medical practices and institutions.
Faculty
Rebecca W. Brendel, MD, JD
Director, Master's Degree Program, Harvard Medical School Center for Bioethics
Dr. Brendel is director of the Master’s Degree Program at the Harvard Medical School Center for Bioethics, of which she is also an associate director. She bases her clinical work in psychiatry at Massachusetts General Hospital where she is the director
of Law and Ethics at the Center for Law, Brain, and Behavior. She is Assistant Professor of Psychiatry at Harvard Medical School.
Rebecca W. Brendel, M.D., J.D. is the president-elect American Psychiatric Association, chair of the Massachusetts
Medical Society Committee on Ethics, Grievances, and Professional Standards, and a member of the American Medical Association (AMA) Council on Ethical and Judicial Affairs.
Dr. Brendel earned her medical degree from the University of Chicago
Pritzker School of Medicine and her law degree from the University of Chicago Law School. She completed her psychiatry residency at Massachusetts General and McLean Hospitals, a forensic psychiatry fellowship at Massachusetts General Hospital, and
an ethics faculty fellowship at the Edmond J. Safra Center for Ethics at Harvard. She is admitted to the Massachusetts Bar.
Sachin Jain, MD, MBA, FACP
President and Chief Executive Officer SCAN Group and SCAN Health Plan
Sachin H. Jain, MD, MBA, FACP is President and CEO of SCAN Group and SCAN Health Plan, where he is charged with leading the organization’s growth, diversification, and emerging efforts to reduce healthcare disparities. SCAN’s revenues top $4.3B and the
organization serves more than 270,000 patients. Under Dr. Jain’s leadership SCAN has maintained its 4.5 STAR rating for the 5th year in a row; offered new products (ISNP) and expanded operations into Arizona and Nevada; launched new subsidiaries focused
on home-based primary care, homeless healthcare, and PACE.
Dr. Jain is also an adjunct professor of medicine at the Stanford University School of Medicine and a contributor at Forbes. Previously, Dr. Jain was President and CEO of CareMore and Aspire Health, innovative care delivery systems with > $1.6B in revenues
serving 200,000 Medicare and Medicaid patients and 2500 associates in 32 states. He led the diversification of CareMore, along with the acquisition and integration of Aspire Health. CareMore and Aspire now operate multiple innovative models of care
including home-based primary care for frail and vulnerable patients; clinic and home-based models for acute and chronic disease management and prevention; home-based palliative care; and virtual care delivery. At CareMore, he pioneered and scaled
the first clinical program in the world focused on social isolation.
Prior to joining CareMore, Dr. Jain was global Chief Medical Information & Innovation Officer at Merck & Co. He contemporaneously served as an attending physician at the
Boston VA-Boston Medical Center and a member of faculties at Harvard Medical School and Harvard Business School. From 2009-2011, Dr. Jain worked in leadership roles at the US Department of Health and Human Services, where he was senior advisor to
the administrator of the Centers for Medicare & Medicaid Services (CMS). Dr. Jain was the first acting deputy director for policy and programs at the Center for Medicare and Medicaid Innovation (CMMI). He also served as special assistant to the National
Coordinator for Health Information Technology.
Dr. Jain is a respected thought leader in health care delivery. He is regularly recognized as a “Top 50 Most Influential Clinical Leader” and “100 Most Influential People in US Healthcare” by
Modern Healthcare. Dr. Jain has also been recognized by the Boston VA Medical Center for excellence in clinical care provided to the veteran’s community with the “Golden Heart Award” and by Brigham and Women’s Hospital for excellence in mentorship.
LinkedIn named him its top voice (#1) for healthcare.
Dr. Jain graduated magna cum laude from Harvard College with a BA in government and continued on to earn his MD from Harvard Medical School and MBA from Harvard Business School. He is
a member of the boards of Cardiovascular Systems Inc (NASDAQ: CSII); Biofourmis; and the Make-A-Wish Foundation. He trained in medicine at the Brigham and Women's Medicine and Harvard Medical School, earned his board certification from the ABIM, and
continues to practice medicine at the West Los Angeles VA Hospital. He is co-founder and co-editor-in-chief of the Elsevier journal Healthcare: The Journal of Delivery Science & Innovation and is an elected member of the National Academy of Social
Insurance (NASI). He has published over 100 articles in journals such as the New England Journal, JAMA, Health Affairs, and the Harvard Business Review blogs and was an editor of the book, The Soul of a Doctor (Algonquin Press). He is an Aspen Institute
Health Innovator’s Fellow and a Paul and Daisy Soros Fellow.
Jane M. Zhu, MD, MPP, MSHP
Jane M. Zhu, MD, MPP, MSHP, is an Assistant Professor of Medicine in the Division of General Internal Medicine at the Oregon Health & Science University. She holds a secondary appointment in Health Systems Management & Policy at the OHSU-PSU School of Public Health and is an adjunct Senior Fellow at the Leonard Davis Institute of Health Economics at the University of Pennsylvania. Dr. Zhu's research centers on health care access and quality, particularly for mental/behavioral health services, as well as the effects of provider incentives and organization of care. Her work has been published in high-impact journals, including JAMA, NEJM, and Health Affairs, and has been cited in government and legislative reports.
Dr. Zhu also is a practicing primary care physician. She obtained her BSc degree in global health and international development from Duke University, where she was awarded a Fulbright fellowship. She received dual degrees in medicine and public policy from Harvard Medical School and Harvard's Kennedy School of Government. After internal medicine residency training at the University of California, San Francisco, she was selected as a National Clinician Scholar at the University of Pennsylvania where she completed a two-year fellowship.
Intended Audience
This activity is designed for health care leaders, physicians, residents, other health care professionals and students in all health care professions..
Course Objectives
Upon
completion of this activity, learners should be able to:
- Describe various types of for-profit financing of health care, including for medical practices
- Appreciate the ethical tensions that arise in for-profit financing of medical institutions
- Apply principles of medical ethics in assessing the potential ethical concerns that various for-profit funding models may pose for physicians
Course Fees
Massachusetts Medical Society (MMS) Physician Member: $40.00
MMS Resident/Student Member: Free
Non-Member Physician: $90.00
Non-Members Resident/Student: $20.00
Allied Health Professional/Other: $32.00
Format & Estimated Time to Complete
Video
(1 hour)
Accreditation and Credit Information
Accreditation Statement
The Massachusetts Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical
education for physicians.
AMA Credit Designation Statement
The Massachusetts Medical Society designates this internet enduring material for a maximum of 1.00 AMA PRA Category 1
Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for the Massachusetts Board of Registration in Medicine for risk management study.
MOC Approval Statement
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, This activity has met the requirements as a Lifelong Learning CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:
Allergy and Immunology
Anesthesiology
Colon and Rectal Surgery
Family Medicine
Physical Medicine and Rehabilitation
Plastic Surgery
Preventive Medicine
Psychiatry and Neurology
Radiology
Thoracic Surgery
Urology
National Commission on Certification of Physicians Assistant
(NCCPA)
Physician Assistants may claim a maximum of 1.00 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Exam/Assessment: A score of 70% or higher is required to receive AMA PRA Category 1 Credit™.
Activity Term
Original Release Date: December 22, 2022
Review Date (s): N/A
Termination Date: December 22, 2025
System Requirements
Desktops/Laptops
Windows 10
Mac OSX 10.6 higher
Most modern browsers including:
IE 11+
Firefox 18.0+
Chrome latest version
Safari 12+
Mobile/Tablet
iOS devices beginning with OS version 10 or higher (includes, iPhone, ipad and iTouch devices)
